RICK DOBLIN, PhD

RICK DOBLIN, PhD

RICK DOBLIN, PhD

FROM ADAM TO ECSTASY TO FDA-APPROVED MDMA-ASSISTED PSYCHOTHERAPY

In the mid 1970s MDMA, then known as Adam was used quietly in psychotherapy. In the 1980s, growing recreational use of Ecstasy led to the criminalization of the drug and the formation of MAPS in 1986. Now, MAPS is about to embark on FDA-approved Phase 3 research to make MDMA-assisted psychotherapy a legal treatment for PTSD. This talk will discuss the historical implications of MDMA use and the plans for ongoing clinical research.

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and one of three children (two in college).